Earlier this year, J.P. Morgan released a report outlining the potential for GLP-1 treatments in other markets. Specifically, ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Losing weight can bolster confidence, but it can also impact how others treat you. Knowing how to manage relationships and ...

Axsome's financials show a market cap of $4.1bn and a cash runway of 4-5 quarters, but risks include potential dilution and FDA approval uncertainty. Learn more on AXSM stock here.

Chitin also triggered increases in levels of glucagon-like peptide-1 (GLP-1), the hormone ... of the chitin-digesting enzyme, ...

Alzamend Neuro, Inc. ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the ...

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...

A clinical trial will test whether a lab-made version of a molecule found in spider venom can reverse tissue damage after a ...

However, in rheumatoid arthritis (RA) – a chronic and progressive autoimmune disease – the immune system doesn’t work properly and attacks the lining of the joints instead, causing pain and ...

This is the most recent version of the national Cancer Drugs Fund list, and replaces any earlier versions. It contains updates to the previous list, as well as new drugs and indications which have ...